154 related articles for article (PubMed ID: 36400059)
1. Orthopaedic Manifestations of Neurofibromatosis Type I.
Evans TJ; Wang X; Binitie O
J Am Acad Orthop Surg; 2022 Dec; 30(23):e1495-e1503. PubMed ID: 36400059
[TBL] [Abstract][Full Text] [Related]
2. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
3. Fetal cardiomyopathy in neurofibromatosis type I: Novel phenotype and review of the literature.
Ritter A; Cuddapah S; Degenhardt K; Kasperski S; Johnson MP; O'Connor MJ; Ahrens-Nicklas R
Am J Med Genet A; 2019 Jun; 179(6):1042-1046. PubMed ID: 30919579
[TBL] [Abstract][Full Text] [Related]
4. Novel germinal mutation in NF1: case report.
Arredondo Montero J; López Arbues S; Bronte Anaut M; Morales Garofalo L; García F
Mol Biol Rep; 2021 Nov; 48(11):7617-7620. PubMed ID: 34596808
[TBL] [Abstract][Full Text] [Related]
5. A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex.
Arun V; Wiley JC; Kaur H; Kaplan DR; Guha A
J Neurosci Res; 2013 Apr; 91(4):494-505. PubMed ID: 23361976
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis type 1 revisited.
Williams VC; Lucas J; Babcock MA; Gutmann DH; Korf B; Maria BL
Pediatrics; 2009 Jan; 123(1):124-33. PubMed ID: 19117870
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension in patients with neurofibromatosis type I.
Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
Abramowicz A; Gos M
Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
[TBL] [Abstract][Full Text] [Related]
9. The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis.
Hakimi MA; Speicher DW; Shiekhattar R
J Biol Chem; 2002 Oct; 277(40):36909-12. PubMed ID: 12191989
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE; Gutmann DH
Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
[TBL] [Abstract][Full Text] [Related]
11. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
[TBL] [Abstract][Full Text] [Related]
12. Developmental abnormalities and cancer predisposition in neurofibromatosis type 1.
Larizza L; Gervasini C; Natacci F; Riva P
Curr Mol Med; 2009 Jun; 9(5):634-53. PubMed ID: 19601812
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA.
Wallis D; Li K; Lui H; Hu K; Chen MJ; Li J; Kang J; Das S; Korf BR; Kesterson RA
Hum Mutat; 2018 Jun; 39(6):816-821. PubMed ID: 29522274
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
[TBL] [Abstract][Full Text] [Related]
15. NF1 frameshift mutation (c.6520_6523delGAGA) association with nervous system tumors and bone abnormalities in a Chinese patient with neurofibromatosis type 1.
Su SY; Zhou X; Pang XM; Chen CY; Li SH; Liu JL
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173220
[TBL] [Abstract][Full Text] [Related]
16. [Gene therapy strategies and prospects for neurofibromatosis type 1].
Zheng T; Zhu B; Wang Z; Li Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Jan; 38(1):1-8. PubMed ID: 38225833
[TBL] [Abstract][Full Text] [Related]
17. NF1 mutations and molecular testing.
Thomson SA; Fishbein L; Wallace MR
J Child Neurol; 2002 Aug; 17(8):555-61; discussion 571-2, 646-51. PubMed ID: 12403553
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
[TBL] [Abstract][Full Text] [Related]
19. Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin.
Welti S; Kühn S; D'Angelo I; Brügger B; Kaufmann D; Scheffzek K
Hum Mutat; 2011 Feb; 32(2):191-7. PubMed ID: 21089070
[TBL] [Abstract][Full Text] [Related]
20. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
Ratner N; Miller SJ
Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
